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Abstact: Fat-infiltrated lymph nodes mostly seen on mammograms (MG) of the 
elderly and obese women. We analyzed the fat infiltration of lymph nodes for its 
potential use in estimating body mass index (BMI). 2D digital MG of 157 women 
assessed by one breast radiologist and one radiology resident. For each patient, the 
largest lymph node chosen as the index by analyzing the medial, lateral oblique 
(MLO) views. The width and length of the node and the hilum, the cortex, and the 
Hilo-cortical ratio (HCR) were measured. Breast density was categorized according 
to the ACR BI-RADS 4th edition and divided into two groups as dense and non-
dense. Obesity was defined as BMI ≥ 30 kg/m2, overweight as BMI <30 and ≥ 25 
kg/m2, normal weight as BMI <25 kg/m2. The association of lymph node dimensions 
and hilum dimensions, breast density, and age with BMI were analyzed. P <0.05 
were considered as statistically significant. Good inter-observer agreements were 
found for most measurements, although the agreement of cortex width was low. The 
lymph node dimensions, hilum dimensions, HCR increased significantly with 
increasing BMI for the measurements of reader 1 (p<0.001 for all). In reader 2, only 
widths of lymph node and hilum related (p<0.05). Cortex width was not associated 
with BMI. There was a statistically significant relationship between BMI and 
mammographic density. Obese women had more non-dense breasts (p <0.001). 
Conclusion axillary lymph node fatty content was found related to BMI and could use 
as an indicator of obesity.  
Keywords: obesity; body mass index; axillary lymph node dimension; 
mammography; breast density 
INTRODUCTION  
Obesity is a serious, multi-factorial, chronic illness that affects patients of all 
ages that continues to increase in prevalence (Ludwig J,1980). The obesity epidemic 
has presented new challenges and prompted investigators to perform research on 
the obesity-related disease. It is a risk factor that increases the incidence and 
mortality of many cancers (Gallagher EJ, 2015). Endometrial, renal, colorectal, and 
breast carcinomas have related to obesity (Rota M, 2015; Zhang X, 2015; Chan DS, 
2014).  
The most accepted measure for obesity is body mass index (BMI), which was 
used 150 years ago by Quetelet. It calculated by dividing the body weight by the 
square of the height (kg/m2). Anthropometric measurements have also use for 
abdominal obesity, which is related to metabolic syndrome (Alberti KG, 2006). In this 
era, different imaging methods have been used, especially for estimating visceral fat 
and liver steatosis. Of the imaging options, magnetic resonance imaging (MRI) is 
considered the safest and most sensitive technique. Dual-energy X-ray 
absorptiometry (DEXA) and computed tomography (CT) can also use for the   
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quantification of the visceral fat, and different image techniques and sequences use. 
Mammography does not count among these imaging methods, but it has some 
features that give an idea about a woman’s BMI (Hudson S, 2018; Florio Alexander 
RM, 2018). Firstly, breast density, which is the amount of radio-dense tissue in the 
breast, has been shown as a well-established risk factor along with age and BMI 
(Hudson S, 2018; McCormack VA, 2006). BMI positively correlated with fatty 
breasts, independent of age (Hudson S, 2018; Hart V, 2015). Also, the axillary lymph 
nodes seen in screening mammograms have been investigated as a biomarker for 
obesity recently (Florio Alexander RM, 2018). They see in very different sizes and 
structures in mammograms. The cortex and fatty hilum are the main parts of them. 
The fatty hilum size, in particular, increases when fat infiltration occurs with aging 
and weight gain (Florio Alexander RM, 2018). Lipomatous atrophy happens with 
aging. Also, with weight gain, ectopic fat accumulation, which sees in different 
organs and systems, causes many pathologies related to obesity. These are 
structural, metabolic, and inflammatory changes that mainly cause organ 
dysfunction. Considering these adverse effects, obesity-related lymphatic disorders 
might be related to fat-infiltrated lymph nodes.  
Screening mammograms have been used widely in breast cancer screening, 
and these can accept as the most accessible modality for evaluating lymph nodes 
without adding any costs. Fat-infiltrated lymph nodes mostly seen on mammograms 
of the elderly and obese women; however, in the literature, only one study was found 
that investigated the fatty changes of lymph nodes related to obesity (Florio 
Alexander RM, 2018). We aimed to analyze the fat infiltration of lymph nodes for its 
potential use in estimating BMI. 
 
MATERIALS AND METHOD  
An institutional review board approved this retrospective study. Patients 
randomly selected from the list of mammography work stations from January through 
February 2019.Two-dimensional full-field digital mammograms were obtained using 
Selenia Hologic units (Hologic Incorporated, Bedford, Massachusetts, USA). Images 
reviewed on Barco 3-megapixel MDCG-3221 monitors (Kortrijk, Belgium). One 
breast radiologist with eight years’ experience and one radiology resident made the 
measurements of the lymph nodes.  
For each patient, the medial-lateral oblique (MLO) views reviewed for visible 
axillary lymph nodes. The single largest lymph node within either axilla was chosen 
as the index node and was included for analysis if at least 80% of the node was 
visible. Two observers measured the width and length of the node and hilum. Also, 
the lymph node cortex measured as the radio-dense outer part of the node, and the 
lymph node hilum measured as the central radiolucent area (Figure 1).  
The Hilo-cortical ratio (HCR) defined as the width of the fatty hilum divided by 
the width of the dense cortex. We evaluated the association of lymph node 
dimensions and hilum dimensions, breast density, and age with BMI. Obesity defined 
as BMI ≥ 30 kg/m2, overweight as BMI <30 and ≥ 25 kg/m2, and normal weight as 
BMI <25 kg/m2.  
Breast density scored as 1, 2, 3, and 4 according to the percentage of 
fibroglandular tissue (< 25%, 25-50%, 50-75%, and >75%, respectively) in 
accordance with the 4th version of the American College of Radiology Breast 
Imaging Reporting and Data System (ACR BI-RADS) lexicon (American College of 
Radiology, 2003). The women then assigned to two different groups. Group 1 
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consisted of women with grade 1 or 2 breast density, and group 2 comprised women 
with grade 3 or 4 breast density.  
All statistical analyses were conducted using SPSS Ver. 20.0 (SPSS, 
Chicago, IL) and MedCalc (Mariakerke, Belgium) software. We did a descriptive 
analysis of all variables. We used one-way analysis of variance (ANOVA) tests to 
compare BMI with the measurements of the lymph nodes. Multivariable linear 
regression models were used to assess the independent associations of lymph node 
dimensions (length and width) with BMI, adjusting for age and breast density. Inter-
rater reliability between the two readers was assessed using the Pearson correlation 
coefficient using a standard interpretation of the strength of association. The 
measurements reported in the manuscript are the measurements of reader 1 (AAG). 
P-values <0.05 were considered statistically significant.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1- Screening mammogram of a 55 year old female with BMI of 32: Right 
medial lateral oblique (MLO) view demonstrates and fat infiltrated axillary lymph 
nodes. Measurement axes are seen as follows: total node length (long black line), 
hilum length (long white line), total node width (short black line), hilum width (short 
white line ), and cortical width (white arrow). 
 
RESULTS AND DISCUSSION  
Axillary lymph nodes detected in 81.5% of the patients (128/157). They were 
commonly visible in women with higher BMI and low mammographic density. The 
overall lymph node dimensions, hilum dimensions, and HCR increased significantly 
with increasing BMI from normal to obese for the measurements of reader 1 
(p<0.001 for all). In reader 2, EB, only widths of lymph node and hilum related with 
BMI (p<0.05). (Reader AAG measurements shown in Table 1). However, cortex 
width was not associated with BMI in both the reader’s evaluation (p =0.52 for EB, p 
=0.26 for AAG). 
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Table 1: Comparisons According to BMI Classification 
 
  BMI n mean±SD Min-Max ap 
     (Median)  
 Lymph Normal 29 18,57±8,00 9-41 (15,5)  
 node Overweight 47 20,59±7,38 8-43 (20) 0,001** 
 lenght Obese 52 24,98±7,89 11-47 (24)  
 
Lymph 
Normal 29 10,23±2,76 6-16 (10)  
 Overweight 47 12,15±4,63 5-31 (12) 0,001**  
node width  Obese 52 14,02±3,88 8-25 (12,5)     
 
Hilus 
Normal 29 11,53±7,03 5-31 (9,5)  
 Overweight 47 13,13±6,99 4-36 (12) 0,001**  
lenght 
Reader Obese 52 17,37±7,75 5-39 (16)    
1  Normal 29 6,17±2,56 3-12 (5)  
 Hilus width Overweight 47 7,63±4,78 2-29 (6) 0,001** 
  Obese 52 9,59±3,95 4-20 (9)  
 
Cortical 
Normal 29 4,43±1,3 2-7 (4)  
 Overweight 47 4,87±1,36 2-10 (5) 0,260  
thickness  
Obese 52 4,93±1,41 2-8 (5) 
 
   
  
Normal 
  0,71-3,67  
 
Hilocortika 29 1,48±0,7 (1,25) 
 
  0,021*  l ratio Overweight 47 1,74±1,51 0,67-9 (1,2)   
  Obese 52 2,23±1,4 0,57-7 (2)  
  Normal 29 23,75±7,57 12,8-40,2 (24)  
 Lymph 
Overweight 
  8,2-54,80  
 node 47 23,27±8,62 (22,3) 0,374   
 lenght 
Obese 
  2,5-46,6  
  52 25,62±9,21 (24,45)      
  Normal 29 11,84±3,35 1,9-18,6 (12,1)  
 Lymph 
Overweight 
  6,3-27,70 
0,014*  node width 47 13,00±4,44 (11,9)    
  Obese 52 14,93±5,01 7,5-28,3 (13,6)  
  Normal 29 16,27±7,33 5,4-34,8 (14,6)  
 Hilus Overweight 47 15,51±7,24 4,5-42,7 (15) 
0,404  lenght    5,5-37,4 
Reader Obese 
   
 52 17,58±8,29 (16,05)  
2 
   
 Normal 29 7,96±3,07 3,6-16,5 (7,4)     
 
Hilus width 
Overweight 47 8,59±4,1 1,9-22,5 (8,7) 
0,044*     3,1-23,4   
Obese 
   
  52 10,22±4,88 (10,05)      
 
Cortical 
Normal 29 4,88±1,82 1,5-10,9 (4,6)  
 Overweight 47 5,07±1,91 2,7-11 (4,4) 0,527  
thickness  Obese 52 5,32±1,45 3-9,4 (5,25)     
  Normal 29 2,00±1,6 0,61-8,2 (1,48)  
 
Hilocortika Overweight 
  0,27-6,43  
 47 1,84±1,09 (1,67) 0,656  
l ratio 
 
    0,61-5,14    
Obese 
   
  
52 2,07±1,17 (1,78) 
 
    
aOne-Way Anova Testi**p<0,01  *p<0,05   
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Useful to existing inter-observer agreements found for most measurements, 
with a Pearson correlation coefficient of 0.72 for lymph node length, and 0.73 for 
hilum length. The moderate inter-observer agreement found with a Pearson 
correlation coefficient of 0.62 for lymph node width, 0.65 for hilum width. The inter-
observer deal of cortex width was seen as low. In both observers, the correlations 
between the width of the lymph node and hilus, and length of the lymph node and 
hilus were found high, but there were no statistically significant relationships between 
cortical thickness and width of hilus or lymph node (Table 2). There was a 
statistically significant relationship between BMI and mammographic density. Obese 
women had more non-dense breasts (p <0.001) (Table 3). 
 
Table 2a: The relationship between cortical thickness and width of lymph node hilus 
 
       Cortical thickness  
       r  p 
   
Reader 1 
Lymph node width 0,086  0,329  
   Hilus width  -0,082  0,354         
   
Reader 2 
Lymph node width 0,211  0,017*  
   
Hilus width 
 
0,116 
 
0,191 
 
       
   r=Pearson Correlation       
 Tablo 2b: The Relationship Between Lymph node Width and Hilus Width 
         
       Lymph node width 
       r  p 
   Reader 1 Hilus width  0,927 0,001**  
   Reader 2 Hilus width  0,895 0,001**  
 r=Pearson Correlation  **p<0,01     
 Tablo 2c: The Relationship Between Lymph node Length and Hilus Length 
         
       Lymph node lenght 
       r  p 
   Reader 1 Hilus lenght  0,794 0,001**  
   Reader 2 Hilus lenght  0,900 0,001**  
   r=Pearson Correlation  **p<0,01     
   Table 3: Evaluation of BMI by Density   
         
     Density 1 Density2 
ap      n % n % 
BMI   Normal  32 36,4 56 63,6 0,001** 
   Overweight 54 51,9 50 48,1   
   Obese  92 75,4 30 24,6   
aPearson Chi-Square  **p<0,01     
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Obesity affects cancer development and cancer progression (Calle EE, 2003). 
The role of obesity in tumorigenesis and cancer progression analyzed in three widely 
held hypotheses: unopposed estrogen, adipokines, and insulin play an essential role 
(Nieman, KM, 2013). The reasons for these are that increased breast epithelial and 
tumor cell proliferation stimulated by hyperinsulinemia and tumor growth fueled 
adipokines within the microenvironment (McGowan MM, 2013).  
Breast cancer mortality is higher in obese women than in non-obese women 
due to being presented at an advanced stage (Stark A, 2010). Also, death attributed 
to co-morbidities, including stroke, metabolic syndrome, and cardiovascular disease. 
We also thought that the higher mortality rate in obese women might be associated 
with increased fat content in the lymph node. Therefore, lymph nodes can easily 
infiltrate by tumor cells. In Obeid et al.’s (Obeid JP, 2017) study, they concluded that 
peri-tumoral fat was associated with axillary lymph node metastasis and peritumoral 
adipokines and microenvironment affect tumor progression. It might also might that 
lymph nodes infiltrated with fatty hilum are more prone to be a host for tumor cells 
with a similar mechanism. Thus, analyzing the lymph node fatty hilus and cortex from 
screening mammograms gains importance. Also, by mammographic density 
analysis, BMI, which is the essential biomarker of obesity, can already be predicted.  
In the literature, it concluded that higher BMI was associated with fatty breast 
density (Gillman J, 2016). In our study, there was a strong relationship between BMI 
and breast density in the same way as in the literature. Also, we found that the width 
of the lymph node and hilum related to BMI (Table 1). Two observers with different 
levels of experience in breast imaging were mostly in moderate agreement with the 
measurements of axillary lymph nodes. However, a low deal sees in the analyses of 
lengths. Even though both observers chose the same lymph nodes, they performed 
measurements without seeing all parts of the nodes. It thought that the 
incompatibility of the measurements was caused by estimating the missing piece of 
the node.  
The only related study was by Florio et al., who concluded that all 
measurements with high intraobserver reliability were positively related to BMI (Florio 
Alexander RM, 2018). Our study suggests that only the width of the hilum and lymph 
nodes could use as an indicator of BMI. The axillary region might be examined using 
screening mammograms in which lymph nodes can analyze without extra cost.  
There are some limitations to the present study. The study population is low. The 
impact of the fatty changes of the nodes in malignant cell dissemination not 
investigated because it was beyond the scope of our study. 
 
CONCLUSION  
Axillary lymph node fatty content found related to BMI. Especially, 
measurements of width appeared to have high reliability between the observers and 
could use as an indicator of BMI. 
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